A positive trend, but no significant correlation, was observed for tumor uptake and progression-free survival and overall survival after combined chemo-immunotherapy.
← all excerpts
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
1
—
—